Association Between Norepinephrine Levels and Abnormal Iron Status in Patients With Chronic Heart Failure: Is Iron Deficiency More Than a Comorbidity?
Open Access
- 19 February 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 8 (4) , e010887
Abstract
Background: Mechanisms underlying iron homeostasis dysregulation in patients with chronic heart failure remain unsettled. In cardiomyocyte models, norepinephrine may lead to intracellular iron depletion, but the potential association between catecholamines (sympathetic activation markers) and iron metabolism biomarkers in chronic heart failure is unknown. Methods and Results: In this cross‐sectional analysis, we studied the association between plasma norepinephrine levels and serum iron status biomarkers indicating iron storage (ferritin), iron transport (transferrin saturation), and iron demand (soluble transferrin receptor) in a prospective cohort of 742 chronic heart failure patients (mean age, 72±11 years; 56% male). Impaired iron status was defined as ferritin P =0.013), but not with impaired iron storage (ferritin 0.05). Adjusted norepinephrine marginal means were significantly higher in patients with impaired iron status compared with those with normal iron status (528 pg/mL [505–551] versus 482 pg/mL [448–518], respectively; P =0.038). Conclusions: In chronic heart failure patients, increased sympathetic activation estimated with norepinephrine levels is associated with impaired iron status and, particularly, dysregulation of biomarkers suggesting impaired iron transport and increased iron demand. Whether the relationship between norepinephrine and iron metabolism is bidirectional and entails causality need to be elucidated in future research.Keywords
This publication has 38 references indexed in Scilit:
- Iron Deficiency is a Key Determinant of Health-Related Quality of Life in Patients with Chronic Heart Failure Regardless of Anaemia StatusEuropean Journal of Heart Failure, 2013
- Mitochondria as a Therapeutic Target in Heart FailureJACC, 2013
- Myocardial and Systemic Iron Depletion in Heart FailureJACC, 2011
- Iron deficiency: an ominous sign in patients with systolic chronic heart failureEuropean Heart Journal, 2010
- Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosolProceedings of the National Academy of Sciences, 2010
- Ferric Carboxymaltose in Patients with Heart Failure and Iron DeficiencyNew England Journal of Medicine, 2009
- Adaptive response of the heart to long-term anemia induced by iron deficiencyAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)European Heart Journal, 2005
- Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart FailureCirculation, 2002
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996